Eli Lilly acquires small biotech for $1.6 billion to strengthen cancer immunotherapy pipeline – STAT
STAT |
Eli Lilly acquires small biotech for $1.6 billion to strengthen cancer immunotherapy pipeline
STAT li Lilly is buying into the cancer immunotherapy business. In a deal announced Thursday, Lilly said it will acquire a small biotech, ARMO Biosciences, for $50 per share, or $1.6 billion. The transaction values ARMO shares at a 68 percent premium to … Lilly Is Spending $1.6 Billion To 'Leapfrog' Merck, Bristol — Will It Work? Eli Lilly Makes A Bold Acquisition; How Lucrative Is It? – Eli Lilly and … How this biotech nearly tripled its IPO price with a buyout in less than 4 months |
